Quarterly report · Q1
4885.TEDINET S100S0P0
Period2023-06-01 → 2023-08-31
Filed2023-10-13
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.5bn | 2023-06-01 → 2023-08-31 | Standalone | Net sales |
| Revenue | ¥6.3bn | 2022-06-01 → 2023-05-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.5bn | 2022-06-01 → 2022-08-31 | Standalone | Net sales |
| Operating income | ¥46m | 2023-06-01 → 2023-08-31 | Standalone | Operating income |
| Operating income | ¥130m | 2022-06-01 → 2022-08-31 | Standalone | Operating income |
| Ordinary income | ¥45m | 2023-06-01 → 2023-08-31 | Standalone | Ordinary income |
| Ordinary income | ¥351m | 2022-06-01 → 2023-05-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥118m | 2022-06-01 → 2022-08-31 | Standalone | Ordinary income |
| Profit before tax | ¥47m | 2023-06-01 → 2023-08-31 | Standalone | Income before income taxes |
| Profit before tax | ¥118m | 2022-06-01 → 2022-08-31 | Standalone | Income before income taxes |
| Net income | ¥23m | 2023-06-01 → 2023-08-31 | Standalone | Profit loss |
| Net income | ¥256m | 2022-06-01 → 2023-05-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥86m | 2022-06-01 → 2022-08-31 | Standalone | Profit loss |
| Total assets | ¥4.8bn | at 2023-08-31 | Standalone | Assets |
| Total assets | ¥4.9bn | at 2023-05-31 | Standalone | Assets |
| Total assets | ¥4.8bn | at 2022-08-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.9bn | at 2023-08-31 | Standalone | Liabilities |
| Total liabilities | ¥3.0bn | at 2023-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.9bn | at 2023-08-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-08-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥715m | at 2023-08-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥853m | at 2023-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥5.76 | 2023-06-01 → 2023-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-06-01 → 2023-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.13 | 2022-06-01 → 2022-08-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥5.64 | 2023-06-01 → 2023-08-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥64.12 | 2022-06-01 → 2023-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.75 | 2022-06-01 → 2022-08-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2022-06-01 → 2023-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 39.0% | at 2023-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2023-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.7% | at 2022-08-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 4,095,500 | at 2023-08-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2023-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2022-08-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥472m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥472m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | segment profit | 2023-06-01 → 2023-08-31 | −¥34m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥215m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥215m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | segment profit | 2023-06-01 → 2023-08-31 | −¥17m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥829m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥829m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥97m |
| —segment total | revenue | 2023-06-01 → 2023-08-31 | ¥1.5bn |
| —segment total | revenue external | 2023-06-01 → 2023-08-31 | ¥1.5bn |
| —segment total | segment profit | 2023-06-01 → 2023-08-31 | ¥46m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-08-31 | ¥46m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥508m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥508m |
| jpcrp040300-q1r_E36350-000Chemical Products Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥26m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥241m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥241m |
| jpcrp040300-q1r_E36350-000Healthy Food Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | −¥711,000 |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥778m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥778m |
| jpcrp040300-q1r_E36350-000Pharmaceutical Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥105m |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥130m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2022-08-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2022-08-31 | ¥130m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 360
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人ト ー マ ツ | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)寺 田 篤 芳 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)宮 嵜 健 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 1526467000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 1516540000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 6291379000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 118448000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 44705000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 350890000 | JPY |
| Net income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 86354000 | JPY |
| Net income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 22666000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 256302000 | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Capital stock (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 143172000 | JPY |
| Capital stock (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 143172000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 143172000 | JPY |
| Total number of issued shares (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 4095500 | |
| Total number of issued shares (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 4095500 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 4095500 | |
| Net assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 1698760000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 1886101000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 1915229000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 4754014000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 4835495000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 4948311000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 23.13 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 5.76 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 67.94 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 22.75 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 5.64 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 64.12 | |
| Dividend paid per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 19.00 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 0.357 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 0.390 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.387 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4095500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 4095500 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 4095500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 4095500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 165200 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |